Junko Ohata

983 total citations
17 papers, 718 citations indexed

About

Junko Ohata is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Junko Ohata has authored 17 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Junko Ohata's work include Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (4 papers). Junko Ohata is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (4 papers). Junko Ohata collaborates with scholars based in Japan, United States and Greece. Junko Ohata's co-authors include Mitsufumi Nishio, Nathan J. Zvaifler, Thomas J. Kipps, John C. Reed, Nobuhiro Tsukada, Shinichi Kitada, Tomoyuki Endo, David L. Boyle, Susan L. Kalled and Dennis A. Carson and has published in prestigious journals such as Blood, The Journal of Immunology and European Journal of Biochemistry.

In The Last Decade

Junko Ohata

17 papers receiving 706 citations

Peers

Countries citing papers authored by Junko Ohata

Since Specialization

Citations

This map shows the geographic impact of Junko Ohata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junko Ohata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junko Ohata more than expected).

Fields of papers citing papers by Junko Ohata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junko Ohata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junko Ohata. The network helps show where Junko Ohata may publish in the future.

Co-authorship network of co-authors of Junko Ohata

This figure shows the co-authorship network connecting the top 25 collaborators of Junko Ohata. A scholar is included among the top collaborators of Junko Ohata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junko Ohata. Junko Ohata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	T lymphocytes and muscle condition act like seeds and soil in a murine polymyositis model 2012 ·Arthritis & Rheumatism ·Naoko Okiyama, Takahiko Sugihara, Takatoku Oida, Junko Ohata, Hiroo Yokozeki, Nobuyuki Miyasaka, Hitoshi Kohsaka	14
2	Phase I study of inotuzumab ozogamicin (CMC‐544) in Japanese patients with follicular lymphoma pretreated with rituximab‐based therapy 2010 ·Cancer Science ·Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake, Toshiki Uchida, Masanobu Kasai, Takashi Oyama, Tatsuya Suzuki, Yukio Kobayashi, Takashi Watanabe, Teruhisa Azuma, Masakazu Mori, Yasuhito Terui, Masahiro Yokoyama, Yuko Mishima, Shunji Takahashi, Chiho Ono, Junko Ohata	46
3	7113 Radiographic findings of drug-induced pneumonitis and clinical correlation in patients with advanced renal cell carcinoma treated with temsirolimus 2009 ·European Journal of Cancer Supplements ·(unknown), G. R. Hudes, (unknown), Charles S. White, Mizue Krygowski, M. Cincotta, Junko Ohata, Ignacio Durán, Anna Berkenblit	9
4	Phase I and Pharmacokinetic Study of Inotuzumab Ozogamicin (CMC- 544) as a Single Agent in Japanese Patients with Follicular Lymphoma Pretreated with Rituximab. 2008 ·Blood ·Kensei Tobinai, Michinori Ogura, Kiyohiko Hatake, Yukio Kobayashi, Takashi Watanabe, Toshiki Uchida, Masanobu Kasai, Masahiro Yokoyama, Yasuhito Terui, Chiho Ono, (unknown), Junko Ohata	5
5	Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts 2007 ·Arthritis & Rheumatism ·Junko Ohata, (unknown), Todd A. Johnson, Shohei Hori, Steven F. Ziegler, Hitoshi Kohsaka	33
6	Fibroblast-Like Synoviocytes of Mesenchymal Origin Express Functional B Cell-Activating Factor of the TNF Family in Response to Proinflammatory Cytokines 2005 ·The Journal of Immunology ·Junko Ohata, Nathan J. Zvaifler, Mitsufumi Nishio, David L. Boyle, Susan L. Kalled, Dennis A. Carson, Thomas J. Kipps	169
7	Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α 2005 ·Blood ·Mitsufumi Nishio, Tomoyuki Endo, Nobuhiro Tsukada, Junko Ohata, Shinichi Kitada, John C. Reed, Nathan J. Zvaifler, Thomas J. Kipps	243
8	BAFF Support Survival of Chronic Lymphocytic Leukemia B Cells by a Pathway Independent of Stromal Derived Factor-1α. 2004 ·Blood ·Mitsufumi Nishio, Nobuhiro Tsukada, Shinichi Kitada, Junko Ohata, Nathan J. Zvaifler, John C. Reed, Thomas J. Kipps	1
9	Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis 2002 ·Clinical & Experimental Immunology ·Junko Ohata, Jinkyo Sakurai, Kiyoshi Saito, Kenzaburo Tani, S Asano, Miyuki Azuma	16
10	Preferential Blockade of CD8+ T Cell Responses by Administration of Anti-CD137 Ligand Monoclonal Antibody Results in Differential Effect on Development of Murine Acute and Chronic Graft-Versus-Host Diseases 2001 ·The Journal of Immunology ·Kazuhisa Nozawa, Junko Ohata, Jinkyo Sakurai, Hiroshi Hashimoto, Hiroaki Miyajima, Hideo Yagita∥, Ko Okumura, Miyuki Azuma	32
11	Blockade of CTLA-4 Signals Inhibits Th2-Mediated Murine Chronic Graft-Versus-Host Disease by an Enhanced Expansion of Regulatory CD8+ T Cells 2000 ·The Journal of Immunology ·Jinkyo Sakurai, Junko Ohata, Kiyoshi Saito, Hiroaki Miyajima, T Hirano, Takao Kohsaka, Shoji ENOMOTO, Ko Okumura, Miyuki Azuma	36
12	Differential expression of phosphatidylethanolamine-binding protein in rat hepatoma cell lines: Analyses of tumor necrosis factor-α-resistant cKDH-8/11 and -sensitive KDH-8/YK cells by two-dimensional gel electrophoresis 2000 ·Electrophoresis ·Yasuhiro Kuramitsu, Masanori Fujimoto, (unknown), Junko Ohata, Kazuyuki Nakamura	6
13	Involvement of CD40 Ligand-CD40 and CTLA4-B7 Pathways in Murine Acute Graft-Versus-Host Disease Induced by Allogeneic T Cells Lacking CD28 1998 ·The Journal of Immunology ·Kiyoshi Saito, Jinkyo Sakurai, Junko Ohata, Takao Kohsaka, Hiroshi Hashimoto, Ko Okumura, Ryo Abe, Miyuki Azuma	75
14	Clinical Study of Recombinant Hepatitis B Vaccine 1988 ·Journal of International Medical Research ·Fumihiro Ichida, Akira Yoshikawa, M. Mizokami, Masakazu Yamamoto, Noriyuki Inaba, H Takamizawa, Takao Ohmura, (unknown), Junko Ohata, Yahiro Uemura, Mitsuhiro Nishida	1
15	Primary structure of Vicia angustifolia proteinase inhibitor 1984 ·European Journal of Biochemistry ·Y Shimokawa, Kenji Kuromizu, (unknown), Junko Ohata, (unknown)	13
16	Isolation and activities of the trypsin-modified vicia angustifolia proteinase inhibitor lacking carboxyl-terminal hexapeptide 1979 ·Biochimica et Biophysica Acta (BBA) - Enzymology ·(unknown), Y Shimokawa, Junko Ohata, Kenji Kuromizu	2
17	Proteinase Inhibitor from Vicia angustifolia L. var. segetalis Koch 1978 ·The Journal of Biochemistry ·(unknown), Junko Ohata, (unknown), Kenji Kuromizu	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact